about
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of mon...
Read More
2.20
0.06
(2.80%)
129.6K
XNAS Volume
XNAS 05 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Adagene Inc - ADR is on 10 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Adagene Inc ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..